NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,812.80+₹51.80 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · SAKAR.NS · INR
Stock price, earnings
Quote as of Oct 30, 2026, 07:18 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Sakar Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 22.22% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Sakar Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Sakar Healthcare Limited, founded in 2004 and based in Ahmedabad, India, is a pharmaceutical company actively involved in the full spectrum of drug development, from research and manufacturing to marketing its products. The company's diverse product line includes liquid oral medications, cephalosporin-based drugs (available as tablets, capsules, and dry powder syrups), various injectable forms such as dry powder injections, and liquid injectable solutions (supplied in ampoules, vials, and lyophilized preparations), alongside oral solid dosages. Their comprehensive portfolio addresses approximately 22 distinct therapeutic categories, encompassing treatments for conditions like acidity, malaria, blood clotting, constipation, respiratory issues, pain, infections, depression, allergies, and nutritional deficiencies, among others. Sakar Healthcare also has a significant global reach, distributing its products to roughly 38 countries across regions including Southeast Asia, other parts of Asia, both English and French-speaking African nations, the Middle East and North Africa, and the United States.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:20 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,812.80+₹51.80 (+2.94%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹9,805.50+₹141.50 (+1.46%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.35% below the high.
₹374.30-₹35.50 (-8.66%)
Ind-Swift Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 12.24% below the high.
₹351.30-₹9.15 (-2.54%)
Titan Biotech Limited’s quoted price sits in the upper half of its reported 52-week range, 20.97% below the high.
₹424.90-₹14.85 (-3.38%)
Fermenta Biotech Ltd.’s quoted price sits in the upper half of its reported 52-week range, 26.8% below the high.
₹244.20-₹7.80 (-3.1%)
Kopran Limited’s quoted price sits in the upper half of its reported 52-week range, 17.44% below the high.
₹205.50-₹3.64 (-1.74%)
Kilitch Drugs (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 23.11% below the high.
₹183.69+₹1.76 (+0.97%)
Wanbury Limited’s quoted price sits in the lower half of its reported 52-week range, 48.57% below the high.
